The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Rabies Vaccine Market Research Report 2025
Synopsis
Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.
There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.
The global Human Rabies Vaccine market was valued at US$ 1056 million in 2023 and is anticipated to reach US$ 1422.9 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share.
Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.
The classification of Human Rabies Vaccine includes Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, and Others. In addition, the proportion of Vero Cell rabies vaccines is about 85%.
Human Rabies Vaccine is widely used for Pre-exposure and Post-exposure. The segment of Human Rabies Vaccine used for Post-exposure and the market share is over 70% of the share.
This report aims to provide a comprehensive presentation of the global market for Human Rabies Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rabies Vaccine.
Report Scope
The Human Rabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Rabies Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Rabies Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals
Segment by Type
Vero Cell
BHK
Chick Embryo Cell
Human Diploid Cells
Others
Segment by Application
Pre-Exposure Vaccine
Post-Exposure Vaccine
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Rabies Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Rabies Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.
There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.
The global Human Rabies Vaccine market was valued at US$ 1056 million in 2023 and is anticipated to reach US$ 1422.9 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share.
Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.
The classification of Human Rabies Vaccine includes Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, and Others. In addition, the proportion of Vero Cell rabies vaccines is about 85%.
Human Rabies Vaccine is widely used for Pre-exposure and Post-exposure. The segment of Human Rabies Vaccine used for Post-exposure and the market share is over 70% of the share.
This report aims to provide a comprehensive presentation of the global market for Human Rabies Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rabies Vaccine.
Report Scope
The Human Rabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Rabies Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Rabies Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals
Segment by Type
Vero Cell
BHK
Chick Embryo Cell
Human Diploid Cells
Others
Segment by Application
Pre-Exposure Vaccine
Post-Exposure Vaccine
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Rabies Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Rabies Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Human Rabies Vaccine Market Overview
1.1 Product Overview and Scope of Human Rabies Vaccine
1.2 Human Rabies Vaccine Segment by Type
1.2.1 Global Human Rabies Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Vero Cell
1.2.3 BHK
1.2.4 Chick Embryo Cell
1.2.5 Human Diploid Cells
1.2.6 Others
1.3 Human Rabies Vaccine Segment by Application
1.3.1 Global Human Rabies Vaccine Market Value by Application: (2024-2030)
1.3.2 Pre-Exposure Vaccine
1.3.3 Post-Exposure Vaccine
1.4 Global Human Rabies Vaccine Market Size Estimates and Forecasts
1.4.1 Global Human Rabies Vaccine Revenue 2019-2030
1.4.2 Global Human Rabies Vaccine Sales 2019-2030
1.4.3 Global Human Rabies Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Rabies Vaccine Market Competition by Manufacturers
2.1 Global Human Rabies Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Rabies Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Rabies Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Human Rabies Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Rabies Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Rabies Vaccine, Product Type & Application
2.7 Human Rabies Vaccine Market Competitive Situation and Trends
2.7.1 Human Rabies Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Rabies Vaccine Players Market Share by Revenue
2.7.3 Global Human Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Rabies Vaccine Retrospective Market Scenario by Region
3.1 Global Human Rabies Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Rabies Vaccine Global Human Rabies Vaccine Sales by Region: 2019-2030
3.2.1 Global Human Rabies Vaccine Sales by Region: 2019-2024
3.2.2 Global Human Rabies Vaccine Sales by Region: 2025-2030
3.3 Global Human Rabies Vaccine Global Human Rabies Vaccine Revenue by Region: 2019-2030
3.3.1 Global Human Rabies Vaccine Revenue by Region: 2019-2024
3.3.2 Global Human Rabies Vaccine Revenue by Region: 2025-2030
3.4 North America Human Rabies Vaccine Market Facts & Figures by Country
3.4.1 North America Human Rabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Rabies Vaccine Sales by Country (2019-2030)
3.4.3 North America Human Rabies Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Rabies Vaccine Market Facts & Figures by Country
3.5.1 Europe Human Rabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Rabies Vaccine Sales by Country (2019-2030)
3.5.3 Europe Human Rabies Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Rabies Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Human Rabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Rabies Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Rabies Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Human Rabies Vaccine Market Facts & Figures by Country
3.7.1 Latin America Human Rabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Rabies Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Human Rabies Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Rabies Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Rabies Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Rabies Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Rabies Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Rabies Vaccine Sales by Type (2019-2030)
4.1.1 Global Human Rabies Vaccine Sales by Type (2019-2024)
4.1.2 Global Human Rabies Vaccine Sales by Type (2025-2030)
4.1.3 Global Human Rabies Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Human Rabies Vaccine Revenue by Type (2019-2030)
4.2.1 Global Human Rabies Vaccine Revenue by Type (2019-2024)
4.2.2 Global Human Rabies Vaccine Revenue by Type (2025-2030)
4.2.3 Global Human Rabies Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Human Rabies Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Rabies Vaccine Sales by Application (2019-2030)
5.1.1 Global Human Rabies Vaccine Sales by Application (2019-2024)
5.1.2 Global Human Rabies Vaccine Sales by Application (2025-2030)
5.1.3 Global Human Rabies Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Human Rabies Vaccine Revenue by Application (2019-2030)
5.2.1 Global Human Rabies Vaccine Revenue by Application (2019-2024)
5.2.2 Global Human Rabies Vaccine Revenue by Application (2025-2030)
5.2.3 Global Human Rabies Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Human Rabies Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bharat Biotech
6.1.1 Bharat Biotech Corporation Information
6.1.2 Bharat Biotech Description and Business Overview
6.1.3 Bharat Biotech Human Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bharat Biotech Human Rabies Vaccine Product Portfolio
6.1.5 Bharat Biotech Recent Developments/Updates
6.2 Bavarian Nordic
6.2.1 Bavarian Nordic Corporation Information
6.2.2 Bavarian Nordic Description and Business Overview
6.2.3 Bavarian Nordic Human Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bavarian Nordic Human Rabies Vaccine Product Portfolio
6.2.5 Bavarian Nordic Recent Developments/Updates
6.3 Sanofi-Pasteur
6.3.1 Sanofi-Pasteur Corporation Information
6.3.2 Sanofi-Pasteur Description and Business Overview
6.3.3 Sanofi-Pasteur Human Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi-Pasteur Human Rabies Vaccine Product Portfolio
6.3.5 Sanofi-Pasteur Recent Developments/Updates
6.4 Chengda Bio
6.4.1 Chengda Bio Corporation Information
6.4.2 Chengda Bio Description and Business Overview
6.4.3 Chengda Bio Human Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chengda Bio Human Rabies Vaccine Product Portfolio
6.4.5 Chengda Bio Recent Developments/Updates
6.5 KANGH
6.5.1 KANGH Corporation Information
6.5.2 KANGH Description and Business Overview
6.5.3 KANGH Human Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 KANGH Human Rabies Vaccine Product Portfolio
6.5.5 KANGH Recent Developments/Updates
6.6 Prcmise
6.6.1 Prcmise Corporation Information
6.6.2 Prcmise Description and Business Overview
6.6.3 Prcmise Human Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Prcmise Human Rabies Vaccine Product Portfolio
6.6.5 Prcmise Recent Developments/Updates
6.7 Henan Grand Biopharma
6.6.1 Henan Grand Biopharma Corporation Information
6.6.2 Henan Grand Biopharma Description and Business Overview
6.6.3 Henan Grand Biopharma Human Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Henan Grand Biopharma Human Rabies Vaccine Product Portfolio
6.7.5 Henan Grand Biopharma Recent Developments/Updates
6.8 Zhuoyi Biological
6.8.1 Zhuoyi Biological Corporation Information
6.8.2 Zhuoyi Biological Description and Business Overview
6.8.3 Zhuoyi Biological Human Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Zhuoyi Biological Human Rabies Vaccine Product Portfolio
6.8.5 Zhuoyi Biological Recent Developments/Updates
6.9 ZhongKe Biopharm
6.9.1 ZhongKe Biopharm Corporation Information
6.9.2 ZhongKe Biopharm Description and Business Overview
6.9.3 ZhongKe Biopharm Human Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ZhongKe Biopharm Human Rabies Vaccine Product Portfolio
6.9.5 ZhongKe Biopharm Recent Developments/Updates
6.10 Ningbo Rongan Biological
6.10.1 Ningbo Rongan Biological Corporation Information
6.10.2 Ningbo Rongan Biological Description and Business Overview
6.10.3 Ningbo Rongan Biological Human Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Ningbo Rongan Biological Human Rabies Vaccine Product Portfolio
6.10.5 Ningbo Rongan Biological Recent Developments/Updates
6.11 Indian Immunologicals
6.11.1 Indian Immunologicals Corporation Information
6.11.2 Indian Immunologicals Human Rabies Vaccine Description and Business Overview
6.11.3 Indian Immunologicals Human Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Indian Immunologicals Human Rabies Vaccine Product Portfolio
6.11.5 Indian Immunologicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Rabies Vaccine Industry Chain Analysis
7.2 Human Rabies Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Rabies Vaccine Production Mode & Process
7.4 Human Rabies Vaccine Sales and Marketing
7.4.1 Human Rabies Vaccine Sales Channels
7.4.2 Human Rabies Vaccine Distributors
7.5 Human Rabies Vaccine Customers
8 Human Rabies Vaccine Market Dynamics
8.1 Human Rabies Vaccine Industry Trends
8.2 Human Rabies Vaccine Market Drivers
8.3 Human Rabies Vaccine Market Challenges
8.4 Human Rabies Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
